IE
OSTX

Israel Englander’s OS Therapies Inc OSTX Stock Holding History

Israel Englander’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,785
Closed -$43.1K – 6493
2025
Q4 		$43.1K Sell
30,785
-62,789
-67% -$113K ﹤0.01% 5752
2025
Q3 		$183K Buy
+93,574
New +$185K ﹤0.01% 5568
2025
Q1 		– Sell
-29,836
Closed -$128K – 6491
2024
Q4 		$128K Sell
29,836
-30,599
-51% -$89.7K ﹤0.01% 5431
2024
Q3 		$169K Buy
+60,435
New +$216K ﹤0.01% 5491

Other funds holding OSTX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Israel Englander's OSTX Position: Q1 2026 in Review

Israel Englander sold out of OS Therapies Inc (OSTX) in Q1 2026, closing a stake of 30,785 shares — an estimated $43.1K sold.

Israel Englander first reported a position in OSTX in Q3 2024 and held it in 4 quarters. The position peaked at $183K in Q3 2025. 29 funds tracked by Wall St. Rank hold OSTX as of Q1 2026.

  • Israel Englander reported no remaining OS Therapies Inc position as of Q1 2026 after selling out during the quarter.
  • Israel Englander sold 30,785 OS Therapies Inc shares in Q1 2026, an estimated $43.1K.
  • Israel Englander first reported a position in OS Therapies Inc in Q3 2024 and held it in 4 quarters.
  • Israel Englander's OS Therapies Inc position peaked at $183K in Q3 2025.
  • 29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.